当前位置:首页 - 行情中心 - 戴维医疗(300314) - 财务分析 - 现金流量表

戴维医疗

(300314)

  

流通市值:21.04亿  总市值:42.16亿
流通股本:1.44亿   总股本:2.88亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金257,090,536.01113,489,644.1586,985,403.59390,211,053.44
  收到的税费返还4,267,246.262,038,998.5410,769,559.193,705,954.95
  收到其他与经营活动有关的现金14,556,785.499,447,438.5724,225,428.8916,274,263.54
  经营活动现金流入小计275,914,567.76124,976,081.21621,980,391.67410,191,271.93
  购买商品、接受劳务支付的现金134,109,672.2973,844,089.29243,350,927.69199,311,108.24
  支付给职工以及为职工支付的现金73,829,133.5647,752,405.84138,153,396.76102,501,528.97
  支付的各项税费14,664,665.518,833,790.6932,891,214.723,308,448.55
  支付其他与经营活动有关的现金57,294,990.326,785,557.27113,718,041.3871,039,544.83
  经营活动现金流出小计279,898,461.66157,215,843.09528,113,580.53396,160,630.59
  经营活动产生的现金流量净额-3,983,893.9-32,239,761.8893,866,811.1414,030,641.34
二、投资活动产生的现金流量:
  取得投资收益收到的现金7,232,314.014,987,890.27,027,933.375,213,287.48
  处置固定资产、无形资产和其他长期资产收回的现金净额56,548.67-49,511.48265.49
  收到的其他与投资活动有关的现金652,900,000315,000,0001,080,000,000720,000,000
  投资活动现金流入小计660,188,862.68319,987,890.21,087,077,444.85725,213,552.97
  购建固定资产、无形资产和其他长期资产支付的现金37,480,130.1821,448,191.18139,689,208.26110,882,919.06
  投资支付的现金--20,000,00020,000,000
  支付其他与投资活动有关的现金585,000,000315,000,0001,190,000,000860,000,000
  投资活动现金流出小计622,480,130.18336,448,191.181,349,689,208.26990,882,919.06
  投资活动产生的现金流量净额37,708,732.5-16,460,300.98-262,611,763.41-265,669,366.09
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金8,504,406.6-51,840,00051,840,000
  支付其他与筹资活动有关的现金1,721,237.04-5,020,091.013,567,874.08
  筹资活动现金流出平衡项目0-00
  筹资活动现金流出小计10,225,643.64-56,860,091.0155,407,874.08
  筹资活动产生的现金流量净额平衡项目0-00
  筹资活动产生的现金流量净额-10,225,643.64--56,860,091.01-55,407,874.08
四、汇率变动对现金及现金等价物的影响641,658.04284,560.49-290,105.15-1,249,375.59
五、现金及现金等价物净增加额24,140,853-48,415,502.37-225,895,148.43-308,295,974.42
  加:期初现金及现金等价物余额331,561,172.15331,561,172.15557,456,320.58557,456,320.58
  期末现金及现金等价物余额355,702,025.15283,145,669.78331,561,172.15249,160,346.16
补充资料:
  净利润50,976,694.29-57,263,314.13-
  资产减值准备971,159.65-5,305,042.07-
  固定资产和投资性房地产折旧10,099,580.07-24,774,085.25-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧10,099,580.07-24,774,085.25-
  无形资产摊销1,119,803.68-1,947,096.03-
  长期待摊费用摊销1,991,109.14-3,560,471.63-
  处置固定资产、无形资产和其他长期资产的损失104,015.1-7,567.96-
  固定资产报废损失14,033.48-8,550.75-
  公允价值变动损失---435,315.07-
  财务费用-238,017.49--358,945.33-
  投资损失-7,928,854.87-10,073,085.92-
  递延所得税202,117.73--1,973,619.6-
  其中:递延所得税资产减少202,117.73--1,973,619.6-
  存货的减少-17,749,429.81--31,051,396.79-
  经营性应收项目的减少-19,702,399.21--2,033,240.95-
  经营性应付项目的增加-25,253,638.4-26,780,115.14-
  现金的期末余额355,702,025.15-331,561,172.15-
  减:现金的期初余额331,561,172.15-557,456,320.58-
  现金及现金等价物的净增加额24,140,853--225,895,148.43-
公告日期2025-08-222025-04-282025-04-092024-10-23
审计意见(境内)标准无保留意见
TOP↑